Soleno Therapeutics to Participate in Upcoming Investor Conferences

Core Insights - Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for rare diseases [2] - The company's lead candidate, DCCR extended-release tablets, has recently completed its Phase 3 development program and is preparing for a New Drug Application (NDA) submission [2] Upcoming Events - Anish Bhatnagar, M.D., CEO of Soleno, will participate in the Jefferies Global Healthcare Conference on June 5, 2024, at 11:30 AM ET [1] - The CEO will also attend the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, at 4:00 PM ET [1] - Live audio webcasts of these events will be available on the company's website [1]